Immunovantinc Stock Filter Stocks by Fundamentals
| IMVT Stock | USD 28.61 0.13 0.45% |
ImmunovantInc fundamentals help investors to digest information that contributes to ImmunovantInc's financial success or failures. It also enables traders to predict the movement of ImmunovantInc Stock. The fundamental analysis module provides a way to measure ImmunovantInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to ImmunovantInc stock.
ImmunovantInc | Shares Owned by Insiders |
ImmunovantInc Institutional Holders
Institutional Holdings refers to the ownership stake in ImmunovantInc that is held by large financial organizations, pension funds or endowments. Institutions may purchase large blocks of ImmunovantInc's outstanding shares and can exert considerable influence upon its management. Institutional holders may also work to push the share price higher once they own the stock. Extensive social media coverage, TV shows, articles in high-profile magazines, and presentations at investor conferences help move the stock higher, increasing ImmunovantInc's value.| Shares | Nuveen Asset Management, Llc | 2023-12-31 | 1.2 M | Logos Global Management Lp | 2023-12-31 | 1.2 M | Cormorant Asset Management, Llc | 2023-12-31 | 1.2 M | Redmile Group, Llc | 2023-09-30 | 1.1 M | Deep Track Capital, Lp | 2023-12-31 | 1000 K | Commodore Capital Lp | 2023-12-31 | 1000 K | Boxer Capital Llc | 2023-12-31 | 1000 K | Rock Springs Capital Management Lp | 2023-12-31 | 983.3 K | Capital Research Global Investors | 2023-12-31 | 976.2 K | Fmr Inc | 2023-12-31 | 7.9 M | Vanguard Group Inc | 2023-12-31 | 5.8 M |
ImmunovantInc Fundamentals
| Return On Equity | -0.45 | ||||
| Return On Asset | -0.27 | ||||
| Current Valuation | 3.47 B | ||||
| Shares Outstanding | 145.29 M | ||||
| Shares Owned By Insiders | 55.53 % | ||||
| Shares Owned By Institutions | 47.62 % | ||||
| Number Of Shares Shorted | 9.02 M | ||||
| Price To Book | 6.28 X | ||||
| EBITDA | (198.28 M) | ||||
| Net Income | (210.96 M) | ||||
| Cash And Equivalents | 427.2 M | ||||
| Cash Per Share | 3.66 X | ||||
| Total Debt | 1.22 M | ||||
| Debt To Equity | 0 % | ||||
| Current Ratio | 21.48 X | ||||
| Book Value Per Share | 4.68 X | ||||
| Cash Flow From Operations | (188.19 M) | ||||
| Short Ratio | 6.97 X | ||||
| Earnings Per Share | (1.81) X | ||||
| Target Price | 50.86 | ||||
| Number Of Employees | 164 | ||||
| Beta | 0.7 | ||||
| Market Capitalization | 4.16 B | ||||
| Total Asset | 405.84 M | ||||
| Retained Earnings | (566.35 M) | ||||
| Working Capital | 361.04 M | ||||
| Net Asset | 405.84 M |
About ImmunovantInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze ImmunovantInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of ImmunovantInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of ImmunovantInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out ImmunovantInc Piotroski F Score and ImmunovantInc Altman Z Score analysis. For more information on how to buy ImmunovantInc Stock please use our How to Invest in ImmunovantInc guide.You can also try the Global Markets Map module to get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes.
Complementary Tools for ImmunovantInc Stock analysis
When running ImmunovantInc's price analysis, check to measure ImmunovantInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ImmunovantInc is operating at the current time. Most of ImmunovantInc's value examination focuses on studying past and present price action to predict the probability of ImmunovantInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ImmunovantInc's price. Additionally, you may evaluate how the addition of ImmunovantInc to your portfolios can decrease your overall portfolio volatility.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data |
Is ImmunovantInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of ImmunovantInc. If investors know ImmunovantInc will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about ImmunovantInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.81) | Return On Assets (0.27) | Return On Equity (0.45) |
The market value of ImmunovantInc is measured differently than its book value, which is the value of ImmunovantInc that is recorded on the company's balance sheet. Investors also form their own opinion of ImmunovantInc's value that differs from its market value or its book value, called intrinsic value, which is ImmunovantInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because ImmunovantInc's market value can be influenced by many factors that don't directly affect ImmunovantInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between ImmunovantInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if ImmunovantInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, ImmunovantInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.